Ralph J. A. Maas - Concepedia

Author

Ralph J. A. Maas

Also Known As

Maas, Ralph J. A., R. J. A. Maas, R.J.A. Maas, Ralph J. A. Maas, Ralph J. Maas, Ralph J.A. Maas, Ralph Ja Maas, Ralph Maas

Publications

326

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Radboud Institute for Molecular Life Sciences University Medical Center Amphia Ziekenhuis

About

Ralph J. A. Maas is an author at Radboud University Nijmegen specializing in medicine, immune regulation, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	67
2	Cell Biology	2	2	67
3	Immunology	2	2	67
4	Autoimmune Disease	1	1	24
5	Autoimmunity	1	1	24

Ralph J. A. Maas

Publications

311

Citations

H-Index

Page 1

	Year	Citations
Cell migration through three-dimensional confining pores: speed accelerations by deformation and recoil of the nucleus Marina Krause, Feng Wei Yang, Mariska te Lindert, Philosophical Transactions of the Royal Society B Biological Sciences	2019	75
Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients Janneke S. Hoogstad‐van Evert, Ralph J. A. Maas, Jolien M.R. Van der Meer, Oncotarget	2018	70
TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer Ralph J. A. Maas, Janneke S. Hoogstad‐van Evert, Jolien M.R. Van der Meer, OncoImmunology	2020	65
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells Jolien M.R. Van der Meer, Ralph J. A. Maas, Karolin Guldevall, Cancer Immunology Immunotherapy Vivo Half-lifeImmunologyImmune RegulationImmunoeditingAllogeneic Natural Killer	2020	43
Human recombinant interleukin-38 suppresses inflammation in mouse models of local and systemic disease Dennis M. de Graaf, Ralph J. A. Maas, Sanne P. Smeekens, Cytokine InflammationCytokineAutoimmune DiseaseImmunologyImmune Regulation	2020	24
CD34 <sup>+</sup> progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg <sup>null</sup> mice Jolien M.R. Van der Meer, Paul K.J.D. de Jonge, Anniek B. van der Waart, OncoImmunology	2021	19
Increased peritoneal TGF-β1 is associated with ascites-induced NK-cell dysfunction and reduced survival in high-grade epithelial ovarian cancer Ralph J. A. Maas, Janneke S. Hoogstad‐van Evert, Iris M. Hagemans, Frontiers in Immunology	2024	15

Page 1